U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 79

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr6:31911323-31911344
GRCh38:
Chr6:31943546-31943567
C2Complement component 2 deficiency, Age related macular degeneration 14, not provided
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr6:31913046
GRCh38:
Chr6:31945269
C2P695L, P478L, P510L, P592L, P724LComplement component 2 deficiency, Age related macular degeneration 14, not provided,
Complement component 2 deficiency
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
3.
GRCh37:
Chr6:31902135
GRCh38:
Chr6:31934358
C2C303YComplement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Mar 30, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr6:31911040
GRCh38:
Chr6:31943263
C2N335H, N438H, N221H, N253H, N467HComplement component 2 deficiencyUncertain significance
(May 21, 2020)
no assertion criteria provided
5.
GRCh37:
Chr6:31902066-31902076
GRCh38:
Chr6:31934289-31934299
C2M251fs, M280fs, M148fsComplement component 2 deficiencyLikely pathogenic
(May 3, 2020)
criteria provided, single submitter
6.
GRCh37:
Chr6:31911430
GRCh38:
Chr6:31943653
C2, CFBK312R, K526R, K394R, K280R, K497RAge related macular degeneration 14, not provided, Complement component 2 deficiency,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Conflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
7.
GRCh37:
Chr6:31903786
GRCh38:
Chr6:31936009
C2, C2-AS1N66K, N180K, N283K, N312KAge related macular degeneration 14, Complement component 2 deficiency, not provided
Conflicting interpretations of pathogenicity
(Aug 20, 2022)
criteria provided, conflicting interpretations
8.
GRCh37:
Chr6:31903779
GRCh38:
Chr6:31936002
C2, C2-AS1N178S, N64S, N281S, N310SAge related macular degeneration 14, Complement component 2 deficiency, not provided
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr6:31903763
GRCh38:
Chr6:31935986
C2, C2-AS1L276F, L59F, L173F, L305FAge related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Feb 9, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr6:31902046
GRCh38:
Chr6:31934269
C2Age related macular degeneration 14, Complement component 2 deficiency, not provided
Uncertain significance
(May 8, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr6:31895509
GRCh38:
Chr6:31927732
C2Age related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr6:31895494
GRCh38:
Chr6:31927717
C2Age related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr6:31913275
GRCh38:
Chr6:31945498
C2Complement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr6:31901976
GRCh38:
Chr6:31934199
C2S221C, S118C, S250CComplement component 2 deficiency, Age related macular degeneration 14, Complement component 2 deficiency,
Age related macular degeneration 14, not provided
Uncertain significance
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr6:31901383
GRCh38:
Chr6:31933606
C2R22HAge related macular degeneration 14, not provided, Complement component 2 deficiency
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
16.
GRCh37:
Chr6:31896709
GRCh38:
Chr6:31928932
C2Complement component 2 deficiency, Age related macular degeneration 14, not provided
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr6:31896638
GRCh38:
Chr6:31928861
C2R100H, R129HComplement component 2 deficiency, Age related macular degeneration 14, not provided
Uncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr6:31913075
GRCh38:
Chr6:31945298
C2R488C, R520C, R734C, R602C, R705CComplement component 2 deficiency, Age related macular degeneration 14, not provided
Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr6:31911054
GRCh38:
Chr6:31943277
C2Complement component 2 deficiency, Age related macular degeneration 14, not provided
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr6:31912582
GRCh38:
Chr6:31944805
C2D415N, D447N, D529N, D632N, D661Nnot provided, Complement component 2 deficiency, Age related macular degeneration 14
Uncertain significance
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr6:31907047
GRCh38:
Chr6:31939270
C2, C2-AS1D144A, D176A, D390A, D361A, D258AComplement component 2 deficiency, Age related macular degeneration 14, not provided
Uncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr6:31905216
GRCh38:
Chr6:31937439
C2, C2-AS1A370V, A124V, A156V, A341V, A238VComplement component 2 deficiency, Age related macular degeneration 14, not provided
Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr6:31905189
GRCh38:
Chr6:31937412
C2, C2-AS1T229M, T147M, T361M, T115M, T332MComplement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr6:31896589
GRCh38:
Chr6:31928812
C2V84M, V113MAge related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Mar 16, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr6:31896535
GRCh38:
Chr6:31928758
C2F66V, F95VComplement component 2 deficiency, Age related macular degeneration 14, not provided
Uncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr6:31895930
GRCh38:
Chr6:31928153
C2A82V, R44WComplement component 2 deficiency, Age related macular degeneration 14, not provided
Uncertain significance
(Jan 26, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr6:31913420
GRCh38:
Chr6:31945643
C2Age related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
28.
GRCh37:
Chr6:31911466
GRCh38:
Chr6:31943689
C2A406V, A292V, A324V, A509V, A538Vnot provided, Age related macular degeneration 14, Complement component 2 deficiency
Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr6:31903830
GRCh38:
Chr6:31936053
C2, C2-AS1N298S, N327S, N195S, N81Snot provided, Age related macular degeneration 14, Complement component 2 deficiency
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr6:31895834
GRCh38:
Chr6:31928057
C2S50F, P12SAge related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr6:31895794
GRCh38:
Chr6:31928017
C2L37FAge related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr6:31895758
GRCh38:
Chr6:31927981
C2P25SAge related macular degeneration 14, not provided, Complement component 2 deficiency
Conflicting interpretations of pathogenicity
(Jun 13, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr6:31903843
GRCh38:
Chr6:31936066
C2, C2-AS1Age related macular degeneration 14, Complement component 2 deficiencyUncertain significance
(Mar 30, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr6:31911738
GRCh38:
Chr6:31943961
C2, CFBR379Q, R461Q, R347Q, R564Q, R593QComplement component 2 deficiency, Age related macular degeneration 14, not provided,
Atypical hemolytic-uremic syndrome
Likely benign
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr6:31918080
GRCh38:
Chr6:31950303
C2, CFBnot specified, Complement component 2 deficiency, not provided,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr6:31917291
GRCh38:
Chr6:31949514
C2, CFBAtypical hemolytic-uremic syndrome with B factor anomaly, Complement component 2 deficiency, Focal segmental glomerulosclerosis,
Macular degeneration, not provided
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr6:31916713
GRCh38:
Chr6:31948936
C2, CFBnot provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with B factor anomaly,
Macular degeneration, Complement component 2 deficiency
Benign/Likely benign
(Feb 1, 2023)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr6:31916707
GRCh38:
Chr6:31948930
C2, CFBnot specified, Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly,
Complement factor b deficiency, Age related macular degeneration 14, not provided,
Atypical hemolytic-uremic syndrome, Kidney disorder, Atypical hemolytic-uremic syndrome with B factor anomaly,
Macular degeneration
Benign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr6:31915819
GRCh38:
Chr6:31948042
C2, CFBnot specified, Complement component 2 deficiency, not provided,
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr6:31915614
GRCh38:
Chr6:31947837
C2, CFBG252SComplement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr6:31915532
GRCh38:
Chr6:31947755
C2, CFBComplement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly,
Kidney disorder, Macular degeneration
Benign/Likely benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr6:31915240
GRCh38:
Chr6:31947463
C2, CFBComplement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr6:31915144
GRCh38:
Chr6:31947367
C2, CFBAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr6:31914935
GRCh38:
Chr6:31947158
C2, CFBComplement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly,
Complement factor b deficiency, Macular degeneration
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr6:31914890
GRCh38:
Chr6:31947113
C2, CFBAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Benign/Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr6:31914306
GRCh38:
Chr6:31946529
C2, CFBR74HAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Conflicting interpretations of pathogenicity
(Sep 21, 2022)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr6:31913438
GRCh38:
Chr6:31945661
C2, CFBAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, Age related macular degeneration 14,
Macular degeneration
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr6:31913317
GRCh38:
Chr6:31945540
C2Complement component 2 deficiency, Age related macular degeneration 14, Macular degeneration
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr6:31913254
GRCh38:
Chr6:31945477
C2Complement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr6:31913216
GRCh38:
Chr6:31945439
C2Complement component 2 deficiency, Age related macular degeneration 14, Macular degeneration
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr6:31913128
GRCh38:
Chr6:31945351
C2Complement component 2 deficiency, not provided, Age related macular degeneration 14
Conflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr6:31913076
GRCh38:
Chr6:31945299
C2R734L, R602L, R520L, R488L, R705LComplement component 2 deficiency, not provided, Inborn genetic diseases,
Age related macular degeneration 14
Uncertain significance
(Jun 26, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr6:31912947
GRCh38:
Chr6:31945170
C2, CFBAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided,
Age related macular degeneration 14, Macular degeneration
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr6:31912773
GRCh38:
Chr6:31944996
C2, CFBAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, Complement component 2 deficiency,
Age related macular degeneration 14, not provided, Age related macular degeneration 14,
Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr6:31912523
GRCh38:
Chr6:31944746
C2, CFBV641A, V509A, V395A, V612A, V427AAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided,
Age related macular degeneration 14, Macular degeneration
Benign/Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr6:31912009
GRCh38:
Chr6:31944232
C2, CFBAtypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided,
Age related macular degeneration 14, Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr6:31912008
GRCh38:
Chr6:31944231
C2Complement component 2 deficiency, not provided, Age related macular degeneration 14,
Macular degeneration
Uncertain significance
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr6:31911936
GRCh38:
Chr6:31944159
C2, CFBS612N, S583N, S398N, S366N, S480NComplement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome,
Age related macular degeneration 14, Macular degeneration
Likely benign
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr6:31911569
GRCh38:
Chr6:31943792
C2K572N, K543N, K326N, K358N, K440NComplement component 2 deficiency, not provided, Age related macular degeneration 14
Uncertain significance
(Aug 7, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr6:31911455
GRCh38:
Chr6:31943678
C2Complement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr6:31911266
GRCh38:
Chr6:31943489
C2, CFBR510H, R296H, R264H, R378H, R481HComplement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome,
Age related macular degeneration 14, Macular degeneration
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr6:31911091
GRCh38:
Chr6:31943314
C2, CFBI484V, I455V, I352V, I238V, I270Vnot provided, Atypical hemolytic-uremic syndrome, Complement component 2 deficiency,
Macular degeneration, Complement component 2 deficiency, Age related macular degeneration 14,
Age related macular degeneration 14
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
63.
GRCh37:
Chr6:31911055
GRCh38:
Chr6:31943278
C2, CFBA472T, A226T, A340T, A443T, A258TComplement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome,
Age related macular degeneration 14, Macular degeneration
Conflicting interpretations of pathogenicity
(Oct 21, 2022)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr6:31910755
GRCh38:
Chr6:31942978
C2Complement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr6:31906997
GRCh38:
Chr6:31939220
C2, C2-AS1Complement component 2 deficiency, not provided, Age related macular degeneration 14
Conflicting interpretations of pathogenicity
(Jul 23, 2022)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr6:31905173
GRCh38:
Chr6:31937396
C2, C2-AS1L356F, L142F, L224F, L110F, L327FComplement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr6:31905130
GRCh38:
Chr6:31937353
C2, C2-AS1Complement component 2 deficiency, not provided, not specified,
Age related macular degeneration 14
Benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr6:31896565
GRCh38:
Chr6:31928788
C2G105R, G76RComplement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr6:31895903
GRCh38:
Chr6:31928126
C2P73L, Q35*Complement component 2 deficiency, Age related macular degeneration 14, not provided
Conflicting interpretations of pathogenicity
(Sep 21, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr6:31895766
GRCh38:
Chr6:31927989
C2Complement component 2 deficiency, Macular degenerationUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
71.
GRCh37:
Chr6:31895493
GRCh38:
Chr6:31927716
C2Complement component 2 deficiency, Age related macular degeneration 14Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr6:31895385
GRCh38:
Chr6:31927608
C2Complement component 2 deficiency, Age related macular degeneration 14Likely benign
(Apr 27, 2017)
criteria provided, single submitter
73.
GRCh37:
Chr6:31918468
GRCh38:
Chr6:31950691
CFBE566AKidney disorder, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly,
Macular degeneration, Complement component 2 deficiency, Complement factor b deficiency
Benign/Likely benign
(Apr 1, 2023)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr6:31918154
GRCh38:
Chr6:31950377
C2, CFBK533RComplement factor b deficiency, Complement factor b deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly,
Age related macular degeneration 14, not provided, Atypical hemolytic-uremic syndrome,
not specified, Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly,
Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr6:31902068-31902095
GRCh38:
Chr6:31934289-31934316
C2V281fsC2-related disorders, Complement component 2 deficiency, Age related macular degeneration 14,
not provided, Complement component 2 deficiency
Pathogenic/Likely pathogenic
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr6:31914024
GRCh38:
Chr6:31946247
C2, CFBL9HComplement factor b deficiency, Age related macular degeneration 14, Atypical hemolytic-uremic syndrome with B factor anomaly,
not specified, not provided, Atypical hemolytic-uremic syndrome,
Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr6:31914179
GRCh38:
Chr6:31946402
C2, CFBR32WFocal segmental glomerulosclerosis, Macular degeneration, Complement component 2 deficiency,
Complement factor b deficiency, Age related macular degeneration 14, Atypical hemolytic-uremic syndrome with B factor anomaly,
Atypical hemolytic-uremic syndrome with B factor anomaly, not provided, Atypical hemolytic-uremic syndrome
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr6:31914180
GRCh38:
Chr6:31946403
C2, CFBR32QAge related macular degeneration 14, Complement component 2 deficiency, not specified,
not provided, Atypical hemolytic-uremic syndrome, Complement component 2 deficiency,
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration, Focal segmental glomerulosclerosis
Benign/Likely benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr6:31903804
GRCh38:
Chr6:31936027
C2, C2-AS1E318D, E72D, E186D, E289DAge related macular degeneration 14, Complement component 2 deficiency, Age related macular degeneration 14,
not specified, not provided, Complement component 2 deficiency
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination